Literature DB >> 17408365

Salmonella-based vaccines for infectious diseases.

Young Min Kwon1, Mandy M Cox, Leona N Calhoun.   

Abstract

The use of Salmonella spp. as a delivery system for foreign antigens represents a unique opportunity for the development of ideal vaccines with unparalleled merits. Increased understanding of the mechanisms underlying Salmonella virulence and host immune response will continuously create novel strategies for more effective Salmonella-based vaccines. However, limitations in our capability to manipulate the genome of a vector strain efficiently have delayed the realization of vaccination ideas. Owing to the development of new technologies in recent years, it has now become feasible to rapidly construct Salmonella vaccine strains that carry precise modifications on the chromosomal DNA. This technical advancement will open a new avenue for the effective development of Salmonella-based vaccines for infectious diseases of both human and animal health importance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408365     DOI: 10.1586/14760584.6.2.147

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  14 in total

1.  Development and Evaluation of CmeC Subunit Vaccine against Campylobacter jejuni.

Authors:  Ximin Zeng; Fuzhou Xu; Jun Lin
Journal:  J Vaccines Vaccin       Date:  2010-01-01

2.  Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi.

Authors:  Silvia I Cazorla; Pablo D Becker; Fernanda M Frank; Thomas Ebensen; María J Sartori; Ricardo S Corral; Emilio L Malchiodi; Carlos A Guzmán
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

3.  Regulated delayed expression of rfc enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines.

Authors:  Qingke Kong; Qing Liu; Angela M Jansen; Roy Curtiss
Journal:  Vaccine       Date:  2010-07-03       Impact factor: 3.641

4.  Therapeutic Efficacy of Phage PIZ SAE-01E2 against Abortion Caused by Salmonella enterica Serovar Abortusequi in Mice.

Authors:  Xinwu Wang; Yalu Ji; Jizuo Su; Yibing Xue; Hengyu Xi; Zijing Wang; Lanting Bi; Rihong Zhao; Hao Zhang; Li Yang; Zhimin Guo; Yuan Guan; Xin Feng; Changjiang Sun; Liancheng Lei; Sadeeq Ur Rahman; Jianbao Dong; Wenyu Han; Jingmin Gu
Journal:  Appl Environ Microbiol       Date:  2020-10-28       Impact factor: 4.792

Review 5.  New technologies in using recombinant attenuated Salmonella vaccine vectors.

Authors:  Roy Curtiss; Wei Xin; Yuhua Li; Wei Kong; Soo-Young Wanda; Bronwyn Gunn; Shifeng Wang
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

6.  A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines.

Authors:  Yuhua Li; Shifeng Wang; Wei Xin; Giorgio Scarpellini; Zhaoxing Shi; Bronwyn Gunn; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

7.  Development of non-antibiotic-resistant, chromosomally based, constitutive and inducible expression systems for aroA-attenuated Salmonella enterica Serovar Typhimurium.

Authors:  Jake N Matic; Tamsin D Terry; David Van Bockel; Tracy Maddocks; David Tinworth; Michael P Jennings; Steven P Djordjevic; Mark J Walker
Journal:  Infect Immun       Date:  2009-02-17       Impact factor: 3.441

8.  Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA.

Authors:  Yuhua Li; Shifeng Wang; Giorgio Scarpellini; Bronwyn Gunn; Wei Xin; Soo-Young Wanda; Kenneth L Roland; Roy Curtiss
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-29       Impact factor: 11.205

9.  Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidate.

Authors:  Jin Hur; John Hwa Lee
Journal:  Clin Vaccine Immunol       Date:  2010-12-15

10.  Immunological characterization of a gidA mutant strain of Salmonella for potential use in a live-attenuated vaccine.

Authors:  Daniel C Shippy; Amin A Fadl
Journal:  BMC Microbiol       Date:  2012-11-30       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.